Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Sexually Transmitted Infections in Men Who Have Sex with Men

Key STIs in MSM

  • Gonorrhea is one of the most common STIs among MSM, with prevalence rates of up to 16% reported in STD clinic settings, according to the American College of Physicians 1
  • Chlamydia is highly prevalent among MSM with rates of approximately 12% in STD clinic settings, as reported by the American College of Physicians 1
  • Syphilis disproportionately affects MSM, with studies documenting an 18% prevalence of HIV co-infection among patients with early syphilis in several large US cities, as reported by the Centers for Disease Control and Prevention (CDC) 2
  • Syphilis outbreaks continue to occur in MSM communities despite declining rates in the general population, according to the CDC 3

Epidemiology and Risk Factors

  • The presence of other STIs increases the risk of HIV acquisition and transmission, as reported by the CDC 4, 5
  • Herpes Simplex Virus type 2 (HSV-2) is prevalent among MSM and can facilitate HIV transmission, according to the CDC 2, 5

Screening Recommendations

  • The CDC recommends annual screening for all sexually active MSM and more frequent screening (every 3-6 months) for MSM with multiple or anonymous partners, those who use drugs during sex, or have partners who engage in these activities 6
  • Comprehensive screening should include testing for gonorrhea and chlamydia at all potential exposure sites (pharynx, rectum, urethra), as recommended by the CDC 7
  • Serologic testing for syphilis and HIV testing are also recommended by the CDC 6, 7
  • Doxycycline post-exposure prophylaxis (doxy PEP) is now recommended by the CDC for MSM and transgender women who have had a bacterial STI diagnosed in the past 12 months 8

Clinical Implications

  • Co-infections are common, particularly HIV and syphilis, requiring comprehensive testing, as reported by the CDC 2, 6

Prevention Strategies

  • Partner notification and treatment are crucial to prevent reinfection, according to the American College of Physicians 1
  • Risk reduction counseling should be provided to all MSM diagnosed with STIs, as recommended by the CDC 3

Lifetime HIV Risk for Black MSM with Recurrent STIs

Risk Factors and Interventions

  • The CDC identifies persons with a history of STDs or more than one sex partner per year as higher-risk populations requiring intensive screening and prevention interventions, including those with recurrent bacterial STIs 9
  • The presence of bacterial STIs increases HIV acquisition risk through multiple mechanisms, including mucosal inflammation and disruption, and increased HIV viral shedding 9, 10
  • The CDC recommends comprehensive STI screening at all exposure sites (pharynx, rectum, urethra) every 3-6 months for high-risk MSM, and risk reduction counseling addressing the synergistic relationship between STIs and HIV transmission 10, 11
  • Behavioral screening must identify actual risk behaviors (recurrent STIs, receptive anal intercourse) rather than accepting patient's subjective risk assessment, as the CDC recommends 10, 12

Prevention and Treatment

  • The CDC recommends offering PrEP (pre-exposure prophylaxis) immediately to individuals who meet clear indications based on recurrent bacterial STI diagnosis, and doxycycline post-exposure prophylaxis (doxy PEP) for MSM who have had bacterial STI diagnosed in past 12 months 10, 13

REFERENCES